BDX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BDX is a good buy right now for a beginner focused on long-term investing with $50,000-$100,000 available. My view is a clear BUY: the stock just reacted positively to a strong Q2 report, management raised full-year EPS guidance, hedge funds are aggressively accumulating, and congress trading is net positive. Even though the chart is still mixed and analyst opinions are split, the combination of improving fundamentals, supportive sentiment, and a reasonable entry near recent resistance breakout levels makes it attractive now rather than waiting.
BDX is in a short-term recovery phase. MACD histogram is positive and expanding, which supports upside momentum. RSI_6 at 62.984 shows strength but not extreme overbought conditions. However, the moving average structure is still bearish overall with SMA_200 > SMA_20 > SMA_5, so the longer trend has not fully turned bullish yet. Price at 154.9448 is just above pivot 148.927 and near R1 at 153.655, which suggests the market has started to reclaim key levels. If this move holds, the next upside area is R2 at 156.576. The technical picture is improving, but not fully confirmed.
["Q2 revenue of about $4.7B beat expectations and management raised FY2026 adjusted EPS guidance to $12.52-$12.72.", "Hedge funds are strongly buying, with buying up 956.90% over the last quarter.", "Congress trading shows 1 purchase and 0 sales in the past 90 days, a positive signal.", "Analyst upgrades remain present, including Evercore ISI resuming coverage with an Outperform rating and $180 target.", "The company is executing its portfolio transition, which some analysts believe could unlock a more stable long-term growth profile."]
["Several analysts cut price targets recently, including TD Cowen, Piper Sandler, RBC, and Goldman Sachs, which shows mixed Wall Street confidence.", "The stock is still in a transition year, and some analysts say meaningful margin expansion may be difficult over the near term.", "Technical trend is not fully bullish yet because longer-term moving averages remain bearish.", "Financial snapshot shows reported Q2 revenue down 10.58% YoY and net income/EPS negative, indicating uneven underlying profitability in the latest quarter data provided.", "RBC noted the stock may remain range-bound without a stronger catalyst."]
In the latest reported quarter, Q2 2026, BDX posted revenue of $4.714B and the news summary says revenue beat expectations, with management raising full-year adjusted EPS guidance. The supplied financial snapshot shows revenue down 10.58% YoY, net income at -$311M, and EPS at -1.11, but gross margin improved to 45.69%, up 3.25% YoY. So the quarter shows a mix of weaker reported earnings metrics but better margin quality and improved guidance, which is more important for long-term investors than the temporary earnings dip.
Analyst sentiment is mixed but leaning constructive. Positive notes: Evercore ISI resumed coverage with Outperform and $180 target; Barclays has Overweight and $202; Citi keeps Buy and previously lifted target; Argus keeps Buy and highlighted attractive valuation. More cautious views: TD Cowen cut to $163 and Hold, Piper Sandler cut to $159 and Neutral, RBC cut to $175 and Sector Perform, Goldman resumed at Neutral with $167. Wall Street is basically split, but the pros still see value and recovery potential, even if near-term growth and margin expansion are debated.
